首頁 > 市場調查報告書 > 製藥

疫苗動物用醫藥

市場調查報告書

商品編碼

1378523

伴侶動物疫苗市場：依產品類型、按類別、按配銷通路、按地區

Companion Animal Vaccine Market, By Product Type, By Species Type, By Distribution Channel, and By Region

出版日期: 2023年10月17日 | 出版商:

Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2023 年，全球伴侶動物疫苗市場價值將達到 33.5 億美元，預測期內（2023-2030 年）年複合成長率為 6.8%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	33.5億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	6.80%	2030年市場規模預測	53.1億美元

圖 1. 2023 年伴侶動物疫苗的全球市場佔有率(%)（依物種類型）

伴侶動物疫苗是給寵物（如狗和貓）給藥的疫苗，以刺激其免疫反應。換句話說，伴侶動物疫苗用於改善寵物和其他動物的免疫系統功能。此外，疫苗接種可以保護伴侶動物和寵物免受多種疾病的侵害，包括細小病毒、犬瘟熱、鉤端螺旋體病、扁桃腺炎、扁桃體炎、貓抓病和犬窩咳。定期接種疫苗是動物保健的重要組成部分，以確保伴侶動物的健康和福祉。市場上營運的主要公司正專注於研發活動、臨床試驗、核准和推出用於伴侶動物治療的新型疫苗，預計將推動全球市場的成長。

市場動態

疫苗產業的主要參與者致力於開發新型疫苗來預防新疾病，例如裂谷熱、藍舌病毒（BTV）等。此外，市場上的主要參與者都專注於動物疫苗開發的無機策略，例如合併、收購和合作。政府增加對疫苗生產和分銷的投資預計將推動伴侶動物疫苗市場的成長。例如，2022年6月，活躍於全球的專門從事生物製藥製造流程開發的研發公司ARTES Biotechnology、總部位於比利時的生物技術公司Q-Biologicals NV以及總部位於德國的多模式色譜技術公司instrAction GmbH ，已合作開發基於病毒樣顆粒（VLP）的疫苗平台和特別適合獸醫應用的穩定製劑。「Plurivax」的目的是開發一個穩定的生產平台和相匹配的高品質工藝，以實現適合多種獸用疫苗的有效且可用的綜合最佳實踐。因此，這種含有病毒樣顆粒（VLP）的產品的上市預計將為疫苗製造商提供開發新動物疫苗的機會。

本研究的主要特點

本報告詳細分析了全球伴侶動物疫苗市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
它還闡明了不同細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
該報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球伴侶動物疫苗市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場經營團隊和行銷策略做出明智的資訊。
全球伴侶動物疫苗市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球伴侶動物疫苗市場時所使用的各種策略矩陣來促進決策。

公司簡介
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck &Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, as

第10章章

參考
調查方法

簡介目錄

Product Code: CMI3387

The global companion animal vaccine market is estimated to be valued at US$ 3.35 Billion in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.35 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.80%	2030 Value Projection:	US$ 5.31 Bn

Figure 1. Global Companion Animal Vaccine Market Share (%), By Species Type, 2023

Companion animal vaccinations are those administered to pets (such as dogs and cats) to stimulate their immune responses. Companion animal vaccines, in other words, are used to improve the functioning of the immune system in pets and other animals. Moreover, vaccination can protect companion animals or pets from a variety of diseases, including parvovirus, distemper, leptospirosis, lastomycosis, psittacosis, cat scratch disease, kennel cough, and others. Routine vaccination is a vital part of animal healthcare that ensures companion animals health and well-being. Key players operating in the market are focusing on research and development activities, clinical trials, approval, and the launch of novel vaccines for the treatment of companion animals, which is expected to drive market growth globally.

Market Dynamics

The key players in the vaccine industry are focusing on the development of novel vaccines for prevention against new diseases such as rift valley fever, Bluetongue Virus (BTV), etc. Moreover, major players in the market are focusing on inorganic stratergies such as mergers, acquisitions, and collaboration for vaccine developments for veterinary applications. Increasing investments by governments to support manufacturing and distribution of vaccines is expected to propel market growth for companion animal vaccine. For instane, In June 2022, ARTES Biotechnology, a globally active Research and development company specializing in developing biopharmaceutical production processes, Q-Biologicals NV, a Belgium-based biotechnology company, and instrAction GmbH, a Germany-based multimodal chromatography technology company, partnered to collaborate on the development of a virus-like particle (VLP)-based vaccine platform and stable formulation especially suited for veterinary applications. The intent of "Plurivax" is to develop a stable production platform and an adapted, high-quality process to have an effective and usable integrated best practice suitable for several veterinary vaccines. Thus, the availability of the product in the market, which includes virus-like particles (VLP), is expected to offer opportunities for vaccine manufacturers to develop novel vaccines for veterinary use.

Key features of the study:

This report provides an in-depth analysis of the global companion animal vaccine market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global companion animal vaccine market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva Ltd., Merck & Co. Inc., Virbac, Zoetis Inc., HIPRA, Biogenesis Bago, Ourofino Animal Health, Croda International Plc, KM Biologics, Indian Immunologicals Ltd., Sinovac, Kyoto Biken Laboratories, Inc., HESTER BIOSCIENCES LIMITED, Calier, Bioveta, a.s
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global companion animal vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal vaccine market

Detailed Segmentation:

Global Companion Animal Vaccine Market , By Product Type:
- Attenuated Live Vaccine
- Conjugate Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Toxoid Vaccine
- DNA Vaccine
- Recombinant Vaccine
Global Companion Animal Vaccine Market , By Species Type:
- Canine
- Feline
- Equine
- Avians
- Others
Global Companion Animal Vaccine Market , By Distribution channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
Global Companion Animal Vaccine Market , By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Elanco Animal Health Incorporated
- Boehringer Ingelheim Gmb
- Ceva Ltd.
- Merck & Co Inc.
- Virbac, Inc.
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, a.s

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Species Type
- Market Snippet, By Distribution Channel
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Product Launches/Approvals
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Companion Animal Vaccine Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Companion Animal Vaccine Market, By Product Type, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Attenuated Live Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trend
Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trend

6. Global Companion Animal Vaccine Market, By Species Type, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Canine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Feline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Equine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Avians
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Companion Animal Vaccine Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Veterinary Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Companion Animal Vaccine Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Elanco Animal Health Incorporated
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck & Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, a.s